Canadian approval for SpectRx:
This article was originally published in Clinica
Executive Summary
SpectRx has received approval to market its BiliCheck non-invasive Bilirubin analyser in Canada. The hand-held device detects infant jaundice by shining a light on the infant's forehead. The light is then reflected back to the spectrometer inside the device and analysed for levels of bilirubin. Results are obtained immediately regardless of the infant's skin colour, gestational or post-natal age. Bilicheck uses the company's BiliCal calibration tips to perform automatic calibration before each measurement.